Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Prothrombin complex concentrate, human is a plasma-derived biologic medication containing nonactivated vitamin K-dependent coagulation factors II, VII, IX, and X as well as proteins C and S. It is used for the urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist (VKA) therapy (such as warfarin) in adult patients with acute major bleeding or who require urgent surgery or invasive procedures. The product works by rapidly restoring depleted clotting factors to promote hemostasis and stop bleeding. Compared to fresh frozen plasma, it provides more rapid INR reduction with lower risk of volume overload. The most common brand name in the US is Kcentra[1][2][4][6][9][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on prothrombin complex concentrate, human.